Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea

European Journal of Surgical Oncology

Volumn 34, Issue 1, 2008, Pages 36-41

  Park, C H ^a   Song, K Y ^a   Kim, S N ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Gastric cancer; Large volume center; Long term survival; Surgical treatment; Trend

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; EARLY CANCER; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STOMACH ADENOCARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 37349034305     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.03.004     Document Type: Article

References (40)

1. Kim J.P., Kwon O.J., Oh S.T., and Yang H.K. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Am Surg 216 (1992) 269-279
2. Nakajima T., Nishi M., and Kajitani T. Improvement in treatment results of gastric cancer with surgery and chemotherapy: experience of 9700 cases in the Cancer Institute Hospital, Tokyo. Semin Surg Oncol 84 (1991) 1474-1478
3. Borch K., Jonsson B., Tarpila E., et al. Changing pattern of histologic type, location, stage and outcome of surgical treatment and the prognosis for Japanese patients with gastric cancer. Br J Cancer 83 (2000) 986-991
4. Sakamoto J., and Yasue M. Extensive lymphadenectomy for gastric cancer patients: what can the results of one trial tell us?. Lancet 345 (1995) 742-743
5. Sobin L.H., and Ch W. TNM classification of malignant tumours. International Union Against Cancer (UICC). 5th ed. (1997), Wiley-Liss, New York p. 59-62
6. Johnson M.L., Gordon H.S., Petersen N.J., et al. Effect of definition of mortality on hospital profiles. Med Care 40 (2002) 7-16
7. Yoo C.H., Noh S.H., Shin D.W., Choi S.H., and Min J.S. Recurrence following curative resection for gastric carcinoma. Br J Surg 87 (2000) 236-242
8. Moriguchi S., Maehara Y., Korenaga D., Sugimachi K., and Nose Y. Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol 1 (1992) 341-346
9. Lim L., Michael M., Mann G.B., and Leong T. Adjuvant Therapy in Gastric Cancer. J Clin Oncol 23 (2005) 6220-6232
10. Mari E., Floriani I., Tinazzi A., et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomized trials. Ann Oncol 11 (2000) 837-843
11. Janunger K.G., Hafstrom L., and Glimelius B. Chemotherapy in gastric cancer: A review and updated meta-analysis. Eur J Surg 168 (2002) 597-608
12. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
13. Yonemura Y., Sawa T., Kinoshita K., et al. Neoadjuvant chemotherapy for high-grade advanced gastric cancer. World J Surg 17 (1993) 256-261
14. Lordick F., Stein H.J., Peschel C., and Siewert J.R. Neoadjuvant therapy for oesophagogastric cancer. Br J Surg 91 (2004) 540-551
15. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for respectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
16. Ajani J.A., Ota D.M., Jessup J.M., et al. Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy. Cancer 68 (1991) 1501-1506
17. Crookes P., Leichman C.G., Leichman L., et al. Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report. Cancer 79 (1997) 1767-1775
18. Maehara Y., Okuyama T., Moriguchi S., et al. Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time. Cancer 70 (1992) 392-395
19. Bonenkamp J.J., Songun I., Hermans J., et al. Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345 (1995) 745-748
20. Cuschieri A., Fayers P., Fielding J., et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. The Surgical Cooperative Group. Lancet 347 (1996) 995-999
21. Lee J.H., Ryu K.W., Lee J.H., et al. Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery. Ann Surg Oncol 13 (2006) 1175-1181
22. Kulig J., Popiela T., Kolodziejczyk P., Sierzega M., and Szczepanik A. Polish Gastric Cancer Study Group. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 193 (2007) 10-15
23. Degiuli M., Sasako M., Calgaro M., et al. Italian Gastric Cancer Study Group. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomized surgical trial. Eur J Surg Oncol 30 (2004) 303-308
24. Marrelli D., Pedrazzani C., Neri A., et al. Complications after extended (D2) and Superextended (D3) Lymphadenectomy for Gastric Cancer: Analysis of Potential Risk Factors. Ann Surg Oncol 14 (2007) 25-33
25. Sano T., Sasako M., Yamamoto S., et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 22 (2004) 2767-2773
26. Feith M., Stein H.J., and Siewert J.R. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin North Am 15 (2006) 751-764
27. Siewert J.R., Feith M., Werner M., and Stein H.J. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 232 (2000) 353-361
28. Meyer W., Popp M., Klinger L., Awad-Allah A., and Gebhardt C. Results of surgical therapy of adenocarcinomas of the esophagogastric junction according to a standardized surgical resection technique. Dig Surg 19 (2002) 269-274
29. Park C.H., Kang W.K., Song K.Y., et al. Adenocarcinoma of the gastroesophageal junction: Application of Siewert classification to the Eastern experience. J Korean Gastric Cancer Assoc 4 (2004) 36-43
30. Kodera Y., Yamamura Y., Shimizu Y., et al. Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert classification to 1777 cases resected at a single institution. J Am Coll Surg 189 (1999) 594-601
31. Devesa S.S., Blot W.J., and Fraumeni J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
32. Brown L.M., and Devesa S.S. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin North Am 11 (2002) 235-256
33. Park S.M., Lim M.K., Shin S.A., and Yun Y.H. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 24 (2006) 5017-5024
34. Ho K.Y., Cheung T.K., and Wong B.C. Gastroesophageal reflux disease in Asian countries: disorder of nature or nurture?. J Gastroenterol Hepatol 21 (2006) 1362-1365
35. El-Serag H.B., Satia J.A., and Rabeneck L. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 54 (2005) 11-17
36. Locke III G.R., Talley N.J., Fett S.L., Zinsmeister A.R., and Melton III L.J. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 106 (1999) 642-649
37. Fass R., Fennerty B., and Vakil N. Nonerosive reflux disease: current concepts and dilemmas. Am J Gastroenterol 96 (2001) 303-314
38. Talamonti M.S., Kim S.P., Yao K.A., et al. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery 134 (2003) 720-727
39. Piso P., Werner U., Lang H., Mirena P., and Klempnauer J. Proximal versus distal gastric carcinoma-what are the differences?. Ann Surg Oncol 7 (2000) 520-525
40. Klein S., Kinney J., Jeejeebhoy K., et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 66 (1997) 683-706